Friday, June 12, 2026

Limpid Clears U.S. Food and Drug Administration Registration, Targets $54B U.S. Pet Food Market With Freeze-Dried Launch

Bio pet food startup Limpid is set to officially launch its brand in the US market this month after completing preparations.

SK Telecom, NVIDIA accelerate A.X K2 development through data and infrastructure collaboration

SK Telecom continues collaboration with NVIDIA in AI model development, enhancing performance and stability of AI training.

Seoul Confirms North Korea Dismantling Some Border Loudspeakers

North Korea begins dismantling propaganda loudspeakers aimed at South Korea, while the South maintains surveillance on the situation.

Tag: empagliflozin

New Diabetes Treatment: Chong Kun Dang’s Dubiempol Sustained Release Tablet Approved for Type 2 Diabetes in Korea

Chong Kun Dang's type 2 diabetes treatment, Dubiempol, gains approval, offering a new option for patients with uncontrolled blood sugar.

Top News

- Our Sponsors Ad -

Follow us